Affymax (OTCMKTS:AFFY) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why

Affymax Inc. (OTCMKTS:AFFY – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0011. Affymax shares last traded at $0.0011, with a volume of 1,400 shares traded.

Affymax Price Performance

Affymax Company Profile

(Get Free Report)

Affymax, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare and underserved diseases. The company leverages its proprietary TransCon® drug delivery platform to create prodrugs that offer sustained, predictable release of active pharmaceutical ingredients. Affymax’s research efforts concentrate on endocrinology and nephrology indications, seeking to address conditions that currently have limited treatment options.

Among its lead product candidates, Affymax is advancing TransCon® PTH for the treatment of hypoparathyroidism and TransCon® Growth Hormone (TransCon® GH) for pediatric growth hormone deficiency.

Read More

• Five stocks we like better than Affymax
• Viasat’s Orbiting Profits: Space Force Jackpot?
• Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
• Alphabet’s Most Overlooked Division Just Had a Big Week
• Cooking Up Profits: Cracker Barrel’s Turnaround